Literature DB >> 28258171

ZNF503/Zpo2 drives aggressive breast cancer progression by down-regulation of GATA3 expression.

Payam Shahi1, Chih-Yang Wang1, Devon A Lawson1, Euan M Slorach1, Angela Lu1, Ying Yu1, Ming-Derg Lai2, Hugo Gonzalez Velozo1, Zena Werb3.   

Abstract

The transcription factor GATA3 is the master regulator that drives mammary luminal epithelial cell differentiation and maintains mammary gland homeostasis. Loss of GATA3 is associated with aggressive breast cancer development. We have identified ZNF503/ZEPPO2 zinc-finger elbow-related proline domain protein 2 (ZPO2) as a transcriptional repressor of GATA3 expression and transcriptional activity that induces mammary epithelial cell proliferation and breast cancer development. We show that ZPO2 is recruited to GATA3 promoter in association with ZBTB32 (Repressor of GATA, ROG) and that ZBTB32 is essential for down-regulation of GATA3 via ZPO2. Through this modulation of GATA3 activity, ZPO2 promotes aggressive breast cancer development. Our data provide insight into a mechanism of GATA3 regulation, and identify ZPO2 as a possible candidate gene for future diagnostic and therapeutic strategies.

Entities:  

Keywords:  GATA3; ZBTB32; ZNF503/ZPO2; breast cancer; tumor metastasis

Mesh:

Substances:

Year:  2017        PMID: 28258171      PMCID: PMC5373372          DOI: 10.1073/pnas.1701690114

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  40 in total

Review 1.  An updated view on transcription factor GATA3-mediated regulation of Th1 and Th2 cell differentiation.

Authors:  Ryoji Yagi; Jinfang Zhu; William E Paul
Journal:  Int Immunol       Date:  2011-06-01       Impact factor: 4.823

2.  GATA3 inhibits breast cancer metastasis through the reversal of epithelial-mesenchymal transition.

Authors:  Wei Yan; Qing Jackie Cao; Richard B Arenas; Brooke Bentley; Rong Shao
Journal:  J Biol Chem       Date:  2010-02-26       Impact factor: 5.157

3.  GATA-3 expression as a predictor of hormone response in breast cancer.

Authors:  Purvi Parikh; Juan P Palazzo; Lewis J Rose; Constantine Daskalakis; Ronald J Weigel
Journal:  J Am Coll Surg       Date:  2005-05       Impact factor: 6.113

4.  Gene expression profiling of primary breast carcinomas using arrays of candidate genes.

Authors:  F Bertucci; R Houlgatte; A Benziane; S Granjeaud; J Adélaïde; R Tagett; B Loriod; J Jacquemier; P Viens; B Jordan; D Birnbaum; C Nguyen
Journal:  Hum Mol Genet       Date:  2000-12-12       Impact factor: 6.150

5.  Molecular portraits of human breast tumours.

Authors:  C M Perou; T Sørlie; M B Eisen; M van de Rijn; S S Jeffrey; C A Rees; J R Pollack; D T Ross; H Johnsen; L A Akslen; O Fluge; A Pergamenschikov; C Williams; S X Zhu; P E Lønning; A L Børresen-Dale; P O Brown; D Botstein
Journal:  Nature       Date:  2000-08-17       Impact factor: 49.962

6.  Mutation of GATA3 in human breast tumors.

Authors:  Jerry Usary; Victor Llaca; Gamze Karaca; Shafaq Presswala; Mehmet Karaca; Xiaping He; Anita Langerød; Rolf Kåresen; Daniel S Oh; Lynn G Dressler; Per E Lønning; Robert L Strausberg; Stephen Chanock; Anne-Lise Børresen-Dale; Charles M Perou
Journal:  Oncogene       Date:  2004-10-07       Impact factor: 9.867

7.  GATA3 mutations define a unique subtype of luminal-like breast cancer with improved survival.

Authors:  Yi-Zhou Jiang; Ke-Da Yu; Wen-Jia Zuo; Wen-Ting Peng; Zhi-Ming Shao
Journal:  Cancer       Date:  2014-01-29       Impact factor: 6.860

8.  ZNF703 gene amplification at 8p12 specifies luminal B breast cancer.

Authors:  Fabrice Sircoulomb; Nathalie Nicolas; Anthony Ferrari; Pascal Finetti; Ismahane Bekhouche; Estelle Rousselet; Aurélie Lonigro; José Adélaïde; Emilie Baudelet; Séverine Esteyriès; Julien Wicinski; Stéphane Audebert; Emmanuelle Charafe-Jauffret; Jocelyne Jacquemier; Marc Lopez; Jean-Paul Borg; Christos Sotiriou; Cornel Popovici; François Bertucci; Daniel Birnbaum; Max Chaffanet; Christophe Ginestier
Journal:  EMBO Mol Med       Date:  2011-02-15       Impact factor: 12.137

9.  The long noncoding RNA SPRY4-IT1 increases the proliferation of human breast cancer cells by upregulating ZNF703 expression.

Authors:  Yongguo Shi; Juan Li; Yangchen Liu; Jie Ding; Yingrui Fan; Yun Tian; Li Wang; Yifan Lian; Keming Wang; Yongqian Shu
Journal:  Mol Cancer       Date:  2015-02-22       Impact factor: 27.401

10.  Meta-analysis of human cancer microarrays reveals GATA3 is integral to the estrogen receptor alpha pathway.

Authors:  Brian J Wilson; Vincent Giguère
Journal:  Mol Cancer       Date:  2008-06-04       Impact factor: 27.401

View more
  14 in total

1.  Overexpressed GATA3 enhances the sensitivity of colorectal cancer cells to oxaliplatin through regulating MiR-29b.

Authors:  Wei Wang; Mei Wang; Jing Xu; Fei Long; Xianbao Zhan
Journal:  Cancer Cell Int       Date:  2020-07-24       Impact factor: 5.722

2.  LncRNA ZNF503-AS1 acts as a tumor suppressor in bladder cancer by up-regulating Ca2+ concentration via transcription factor GATA6.

Authors:  Haiqing He; Shuiqing Wu; Kai Ai; Ran Xu; Zhaohui Zhong; Yinhuai Wang; Lei Zhang; Xiaokun Zhao; Xuan Zhu
Journal:  Cell Oncol (Dordr)       Date:  2020-10-01       Impact factor: 6.730

3.  Primary Renal Carcinoid with Bilateral Multiple Clear Cell Papillary Renal Cell Carcinomas.

Authors:  Daniel A Anderson; Maria S Tretiakova
Journal:  Case Rep Pathol       Date:  2017-05-23

4.  Znf703 is a novel RA target in the neural plate border.

Authors:  Amanda Janesick; Weiyi Tang; Kristen Ampig; Bruce Blumberg
Journal:  Sci Rep       Date:  2019-06-04       Impact factor: 4.379

5.  Novel replisome-associated proteins at cellular replication forks in EBV-transformed B lymphocytes.

Authors:  Huanzhou Xu; Ramon D Perez; Tiffany R Frey; Eric M Burton; Sudha Mannemuddhu; John D Haley; Michael T McIntosh; Sumita Bhaduri-McIntosh
Journal:  PLoS Pathog       Date:  2019-12-16       Impact factor: 6.823

6.  N6-Methyladenosine-Related LncRNAs Are Potential Remodeling Indicators in the Tumor Microenvironment and Prognostic Markers in Osteosarcoma.

Authors:  Zhongguang Wu; Xiaobo Zhang; Dongjie Chen; Zian Li; Xin Wu; Jianlong Wang; Youwen Deng
Journal:  Front Immunol       Date:  2022-01-12       Impact factor: 7.561

7.  LncRNA ZNF503-AS1 promotes RPE differentiation by downregulating ZNF503 expression.

Authors:  Xue Chen; Chao Jiang; Bing Qin; Guohua Liu; Jiangdong Ji; Xiantao Sun; Min Xu; Sijia Ding; Meidong Zhu; Guofu Huang; Biao Yan; Chen Zhao
Journal:  Cell Death Dis       Date:  2017-09-07       Impact factor: 8.469

8.  Zinc Finger Protein 521, Negatively Regulated by MicroRNA-204-5p, Promotes Proliferation, Motility and Invasion of Gastric Cancer Cells.

Authors:  Chen Huan; Cai Xiaoxu; Ren Xifang
Journal:  Technol Cancer Res Treat       Date:  2019-01-01

9.  A panel of Transcription factors identified by data mining can predict the prognosis of head and neck squamous cell carcinoma.

Authors:  Boxin Zhang; Haihui Wang; Ziyan Guo; Xinhai Zhang
Journal:  Cancer Cell Int       Date:  2019-11-15       Impact factor: 5.722

10.  Zinc-finger protein p52-ZER6 accelerates colorectal cancer cell proliferation and tumour progression through promoting p53 ubiquitination.

Authors:  Can Huang; Shourong Wu; Wenfang Li; Arin Herkilini; Makoto Miyagishi; Hezhao Zhao; Vivi Kasim
Journal:  EBioMedicine       Date:  2019-09-11       Impact factor: 8.143

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.